<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/General%20Medicine/Opioid%20Analgesia/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Opioid Analgesia - MedNotes</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Opioid Analgesia", url: "#_top", children: [
              {title: "Pharmacology", url: "#pharmacology" },
              {title: "Opioid Equianalgesic Conversion Tables", url: "#opioid-equianalgesic-conversion-tables" },
              {title: "Notable Opioids", url: "#notable-opioids" },
              {title: "Opioid Neurotoxicity", url: "#opioid-neurotoxicity" },
              {title: "References", url: "#references" },
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Unintentional%20Weight%20Loss/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Unintentional%20Weight%20Loss/" class="btn btn-xs btn-link">
        Unintentional Weight Loss
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Intravenous%20Fluids/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Intravenous%20Fluids/" class="btn btn-xs btn-link">
        Intravenous Fluids
      </a>
    </div>
    
  </div>

    

    <h1 id="opioid-analgesia">Opioid Analgesia</h1>
<h2 id="pharmacology">Pharmacology</h2>
<ul>
<li><strong>codone</strong> opioids undergo Phase 1 metabolism by CYP enzymes to their corresponding <strong>morphone</strong> drugs. For example, <em>oxycodone</em> becomes <em>oxymorphone</em> and <em>hydrocodone</em> becomes <em>hydromorphone</em>.</li>
</ul>
<h2 id="opioid-equianalgesic-conversion-tables">Opioid Equianalgesic Conversion Tables</h2>
<table>
<thead>
<tr>
<th>Opioid</th>
<th>Oral Morphine Mg Equivalent (MME)</th>
<th>Initial Adult Oral Dose</th>
</tr>
</thead>
<tbody>
<tr>
<td>Morphine</td>
<td>1</td>
<td>5-20 mg q4h</td>
</tr>
<tr>
<td>Hydromorphone</td>
<td>5</td>
<td>1-4 mg po q4h</td>
</tr>
<tr>
<td>Codeine</td>
<td>0.15</td>
<td>15-60mg q4h</td>
</tr>
<tr>
<td>Oxycodone</td>
<td>1.5</td>
<td>5-10 mg q4h</td>
</tr>
</tbody>
</table>
<h2 id="notable-opioids">Notable Opioids</h2>
<h3 id="morphine">Morphine</h3>
<p><em>Initial dose: 0.05 mg/kg IV</em></p>
<p>The gold standard for comparing all other opioids' effectiveness and adverse reactions. Generally considered the first-choice opioid.</p>
<p>M3G metabolite has neuroexcitatory properties which contributes to toxicity. M6G active metabolite is renally cleared, and theoretically contributes to respiratory depression.</p>
<h3 id="hydromorphone">Hydromorphone</h3>
<p><em>Onset of IV action is 5-20 minutes due to its high lipid solubility.</em></p>
<p>Consider this more strongly in renal disease as relatively lower concentration of renally cleared metabolites is produced. However, its HM3G metabolite is 2.5x more neuroexcitatory than M3G. It does not have an analgesically active metabolite unlike morphine.</p>
<p>Internists tend to prefer this, although dosing errors are more common due to the small quantities this drug is dispensed in relative to morphine.</p>
<h3 id="codeine">Codeine</h3>
<p>A significant number of people are either poor or rapid metabolizers of codeine (to its morphine metabolite), which can lead to toxicity (in both groups) and/or poor treatment of their pain.</p>
<h3 id="tramadol">Tramadol</h3>
<p>Risk for serotonin syndrome and other toxicity due to inhibition of <a href="../../Critical%20Care/Shock%20and%20Resuscitation/Vasopressors/">norepinephrine</a> and serotonin reuptake. <strong>Avoid with MAO inhibitors, SSRIs, SNRIs</strong>.</p>
<h3 id="fentanyl">Fentanyl</h3>
<h3 id="methadone">Methadone</h3>
<h2 id="opioid-neurotoxicity">Opioid Neurotoxicity</h2>
<p>Signs:</p>
<ul>
<li>myoclonus</li>
<li>decreased respiratory rate</li>
<li>miosis</li>
</ul>
<h2 id="references">References</h2>
<ol>
<li><a href="https://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b08.html">Canadian Guideline for Opioid Use for Pain â€” Appendix B-8: Opioid Conversion and Brand Availability in Canada (mcmaster.ca)</a></li>
<li><a href="https://www.aafp.org/dam/AAFP/documents/patient_care/pain_management/conversion-table.pdf">Chronic Pain Management Toolkit - Conversion Table (aafp.org)</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704133/">Opioid Metabolism (nih.gov)</a></li>
<li><a href="https://www.jpsmjournal.com/article/S0885-3924(05)00033-3/fulltext">Hydromorphone - Journal of Pain and Symptom Management (jpsmjournal.com)</a></li>
</ol>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Unintentional%20Weight%20Loss/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Unintentional%20Weight%20Loss/" class="btn btn-xs btn-link">
        Unintentional Weight Loss
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Intravenous%20Fluids/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Intravenous%20Fluids/" class="btn btn-xs btn-link">
        Intravenous Fluids
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>